Cargando…

Minimal Functional β-Cell Mass in Intraportal Implants That Reduces Glycemic Variability in Type 1 Diabetic Recipients

OBJECTIVE: Previous work has shown a correlation between β-cell number in cultured islet cell grafts and their ability to induce C-peptide secretion after intraportal implantation in C-peptide–negative type1 diabetic patients. In this cross-sectional study, we examined the minimal functional β-cell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gillard, Pieter, Hilbrands, Robert, Van de Velde, Ursule, Ling, Zhidong, Lee, Da Hae, Weets, Ilse, Gorus, Frans, De Block, Christophe, Kaufman, Leonard, Mathieu, Chantal, Pipeleers, Daniel, Keymeulen, Bart
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816855/ https://www.ncbi.nlm.nih.gov/pubmed/24041683 http://dx.doi.org/10.2337/dc13-0128

Ejemplares similares

The MicroRNA Landscape of Acute Beta Cell Destruction in Type 1 Diabetic Recipients of Intraportal Islet Grafts
por: Martens, Geert A., et al.
Publicado: (2021)

Graves Hyperthyroidism After Stopping Immunosuppressive Therapy in Type 1 Diabetic Islet Cell Recipients With Pretransplant TPO Autoantibodies
por: Gillard, Pieter, et al.
Publicado: (2009)

Prediction of Impending Type 1 Diabetes through Automated Dual-Label Measurement of Proinsulin:C-Peptide Ratio
por: Van Dalem, Annelien, et al.
Publicado: (2016)

Correction: Prediction of Impending Type 1 Diabetes through Automated Dual-Label Measurement of Proinsulin:C-Peptide Ratio
por: Van Dalem, Annelien, et al.
Publicado: (2017)

Preexisting Insulin Autoantibodies Predict Efficacy of Otelixizumab in Preserving Residual β-Cell Function in Recent-Onset Type 1 Diabetes
por: Demeester, Simke, et al.
Publicado: (2015)

A randomised, single-blind, placebo-controlled, dose-finding safety and tolerability study of the anti-CD3 monoclonal antibody otelixizumab in new-onset type 1 diabetes
por: Keymeulen, Bart, et al.
Publicado: (2020)

Differences in Baseline Lymphocyte Counts and Autoreactivity Are Associated With Differences in Outcome of Islet Cell Transplantation in Type 1 Diabetic Patients
por: Hilbrands, Robert, et al.
Publicado: (2009)

Contribution of Antibodies Against IA-2β and Zinc Transporter 8 to Classification of Diabetes Diagnosed Under 40 Years of Age
por: Vermeulen, Ilse, et al.
Publicado: (2011)

β-Cell Replication Is Increased in Donor Organs From Young Patients After Prolonged Life Support
por: Veld, Peter In't, et al.
Publicado: (2010)

Insulitis in the pancreas of non-diabetic organ donors under age 25 years with multiple circulating autoantibodies against islet cell antigens
por: Smeets, Silke, et al.
Publicado: (2021)

Serum Cytokines as Biomarkers in Islet Cell Transplantation for Type 1 Diabetes
por: van der Torren, Cornelis R., et al.
Publicado: (2016)

Utility of Islet Cell Preparations From Donor Pancreases After Euthanasia
por: De Paep, Diedert L., et al.
Publicado: (2022)

Potential of Protein Phosphatase Inhibitor 1 As Biomarker of Pancreatic β-Cell Injury In Vitro and In Vivo
por: Jiang, Lei, et al.
Publicado: (2013)

CTLA4, SH2B3, and CLEC16A diversely affect the progression of early islet autoimmunity in relatives of Type 1 diabetes patients
por: Vandewalle, Julie, et al.
Publicado: (2023)

Cellular Islet Autoimmunity Associates with Clinical Outcome of Islet Cell Transplantation
por: Huurman, Volkert A. L., et al.
Publicado: (2008)

Genetic variation at ERBB3/IKZF4 and sexual dimorphism in epitope spreading in single autoantibody-positive relatives
por: Vandewalle, Julie, et al.
Publicado: (2021)

Oxygenation of the Intraportally Transplanted Pancreatic Islet
por: Suszynski, Thomas M., et al.
Publicado: (2016)

The Influence of Microenvironment on Survival of Intraportal Transplanted Islets
por: Yan, Ling-ling, et al.
Publicado: (2022)

HLA-A*24 Is an Independent Predictor of 5-Year Progression to Diabetes in Autoantibody-Positive First-Degree Relatives of Type 1 Diabetic Patients
por: Mbunwe, Eric, et al.
Publicado: (2013)

An analytical comparison of three immunoassay platforms for subpicomolar detection of protein biomarker GAD65
por: Costa, Olivier R., et al.
Publicado: (2018)

Pharmacology and antitumour effects of intraportal pirarubicin on experimental liver metastases.
por: Ramirez, L. H., et al.
Publicado: (1993)

Positron Emission Tomography to Assess the Outcome of Intraportal Islet Transplantation
por: Eriksson, Olof, et al.
Publicado: (2016)

Lower beta cell yield from donor pancreases after controlled circulatory death prevented by shortening acirculatory warm ischemia time and by using IGL-1 cold preservation solution
por: De Paep, Diedert L., et al.
Publicado: (2021)

OR03-6 Further Clinical Evaluation of Stem Cell-Derived Islet Replacement Therapy (VC-02) Demonstrates Production of C-Peptide with Improvements in Glycemic Control Parameters in Multiple Patients with Type 1 Diabetes and Hypoglycemia Unawareness
por: Bellin, Melena, et al.
Publicado: (2022)

A surgical method for continuous intraportal infusion of gut microbial metabolites in mice
por: Orabi, Danny, et al.
Publicado: (2021)

The Fate of Allogeneic Pancreatic Islets following Intraportal Transplantation: Challenges and Solutions
por: Li, Xinyu, et al.
Publicado: (2018)

Short-term inhalation of isoflurane improves the outcomes of intraportal hepatocyte transplantation
por: Nishimaki, Hiroyasu, et al.
Publicado: (2022)

Increased Numbers of Low-Oxygenated Pancreatic Islets After Intraportal Islet Transplantation
por: Olsson, Richard, et al.
Publicado: (2011)

Preparatory studies of composite mesenchymal stem cell islets for application in intraportal islet transplantation
por: Duprez, Ida Rasmusson, et al.
Publicado: (2011)

Thioredoxin-1 Attenuates Early Graft Loss after Intraportal Islet Transplantation in Mice
por: Asami, Kengo, et al.
Publicado: (2013)

Composite Mesenchymal Stromal Cell Islets: Implications for Transplantation via the Clinically Preferred Intraportal Route
por: Rackham, Chloe L., et al.
Publicado: (2018)

Rupture of totally implantable central venous access devices (Intraports) in patients with cancer: report of four cases
por: Filippou, Dimitrios K, et al.
Publicado: (2004)

Liver Glycogen Loading Dampens Glycogen Synthesis Seen in Response to Either Hyperinsulinemia or Intraportal Glucose Infusion
por: Winnick, Jason J., et al.
Publicado: (2013)

Tumor Regression in HCC Patient with Portal Vein Tumor Thrombosis after Intraportal Radiofrequency Thermal Ablation
por: Mizandari, Malkhaz, et al.
Publicado: (2016)

Cell Mass Increase Associated with Formation of Glucose‐Controlling β‐Cell Mass in Device‐Encapsulated Implants of hiPS‐Derived Pancreatic Endoderm
por: Robert, Thomas, et al.
Publicado: (2019)

Increase in Anti-Gal IgM Level is Associated With Early Graft Failure in Intraportal Porcine Islet Xenotransplantation
por: Kang, Hee Jung, et al.
Publicado: (2015)

Mitomycin C treatment improves pancreatic islet graft longevity in intraportal islet transplantation by suppressing proinflammatory response
por: Yamane, Kei, et al.
Publicado: (2020)

Protein Markers for Insulin-Producing Beta Cells with Higher Glucose Sensitivity
por: Martens, Geert A., et al.
Publicado: (2010)

Markedly Decreased Blood Perfusion of Pancreatic Islets Transplanted Intraportally Into the Liver: Disruption of Islet Integrity Necessary for Islet Revascularization
por: Henriksnäs, Johanna, et al.
Publicado: (2012)

The intraportal injection model: A practical animal model for hepatic metastases and tumor cell dissemination in human colon cancer
por: Thalheimer, Andreas, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_lmm857gaf5ro319brrn4ud5igd